Injectable drug delivery is a method for direct introduction of a pharmaceutical drug in body of the patient with the help of a delivery device such as auto-injectors, pen-injectors, needle-free injectors etc. The global injectable drug delivery market is expected to rise at a CAGR of 12% during the forecast period 2016-2023. Injectable drug delivery method provides controlled release, needle free delivery, targeted drug delivery, hence overcoming limitations if conventional drug delivery. It also improves quality of therapy. Injectable drug delivery is applied in cases such as unconsciousness, nausea, emergency conditions etc. This method is pyrogen (bacteria) free, isotonic and sterlite. New drug & product launch is adding growth in the global injectable drug delivery market during the forecast period.

Increase in pharmaceutical and biotechnology industry is contributing to the growth of the global injectable drug delivery market during forecast period. According to Drug, Chemical and Associated Technologies (DCAT), total global spending on medicine is expected to reach $1.5 trillion by the end of 2021, up by 33% from 2016. New drug discovery demands efficient injectable drug delivery methods therefore adding growth in the global injectable drug delivery market during the forecast period.

Source: OBRC Analysis

The report on global injectable drug delivery market is segmented on the basis of its segments which include type, formulation, therapeutic application, usage pattern and end users.

Types of injectable drug delivery include:

• Devices
• Formulations

Formulation packaging in injectable drug delivery is divided as:

• Ampules
• Bottles
• Cartridges
• Vials

Therapeutic applications of injectable drug delivery include:

• Auto immune diseases
• Hormonal disorders
• Oncology
• Orphan diseases
• Others

Usage pattern segment of injectable drug delivery can be sub divided as:

• Curative care
• Immunization
• Others

End users of injectable drug delivery include:

• Hospitals
• Homecare
• Others (Research institutes, clinical, diagnostic laboratories)

The report scope is widely categorized on the basis of its segments such as type, formulation, therapeutic application, usage pattern and end users. Moreover, the market revenue estimates and forecast includes only injectable drug delivery methods. However, report scope excludes mechanical drug delivery methods.

Geographically, the global injectable drug delivery market report has been segmented in:

• North America (U.S. & Canada)
• Asia Pacific (China, India, Japan, RoAPAC)
• Europe (UK, France, Germany, RoE)
• Rest of World

North America accounted for the largest market share in terms of revenue for injectable drug delivery market in 2016 and the region is expected to dominate the market during the forecast period followed by Europe. The dominance of the region is attributed to technologically advanced healthcare facilities in the countries of the region such as United States, Canada, etc. United States majorly contributes to the dominance of North America in injectable drug delivery market. Moreover, Food and Drug Administration (FDA) approved drug and vaccine launches such as Zepatier, Briviact, Taltz etc. is adding growth in the injectable drug delivery market in North America during the forecast period. Furthermore, presence of major market players in Germany contributes to the growth of injectable drug delivery market in Europe during the forecast period. However, Asia Pacific is expected to be the fastest growing region for injectable drug delivery market during the forecast period. The highest growth in the region is observed due to enhancing healthcare infrastructure and prevalence of chronic diseases in countries of the region such as China, India, South Korea and Japan which raises the need for effective drug delivery systems thus fueling growth in Asia Pacificinjectable drug delivery market during the forecast period.

Global injectable drug delivery market report covers segmentation analysis of type, formulation, therapeutic application, usage pattern and end users. Report further covers segmentsof type which includes device and formulations. Devices include self-injection devices and conventional injection devices whereas formulations include conventional drug delivery and novel drug delivery. Devices accounted for the largest market share in terms of revenue in 2016 and it is expected to dominate the segment during the forecast period owing to rising usage in management and control of various disorders at primary level.Also, needle free injectionallows painless administration of the medicinal drug, which adds growth of the segment during the forecast period. Formulation packaging in injectable drug delivery is divided as ampoules, bottles, cartridges and vials. Moreover, therapeutic applications of injectable drug delivery include auto immune diseases, hormonal disorders, oncology, orphan diseases and other applications. Oncology accounted for the largest market share in terms of revenue in 2016 and it is expected to dominate the segment during the forecast period owing to increasing application of injectable drug delivery in diagnosis and treatment of cancer (chemotherapy) and diabetes (admission of insulin through auto-injectors, pen-injectors and needle-free injectors). Furthermore, usage pattern segment of injectable drug delivery can be sub divided as curative care, immunization and others. Also, end users of injectable drug delivery include hospitals, homecare and others (Research institutes, clinical, diagnostic laboratories). The homecare segment accounted for the largest market share in terms of revenue in 2016 and it is expected to dominate the segment during the forecast period owing to increasing demand for self-injection devices which provides easy administration of drugs at home without medical assistance.

The major market players of the global injectable drug delivery market are:

• SCHOTT AG
• PFIZER
• GERRESHEIMER AG
• BECTON DICKINSON AND COMPANY
• BAXTER INTERNATIONAL
• OTHERS

These companies using various strategies such as merger & acquisition, collaboration, partnership and product launch whereas, product launch is the key strategy adopted by the companies in the global injectable drug dellivery market.

For example:In 2017, Vetter and Microdermics signed a strategic partnership agreement. The major aim of the partnership was to manufacture and develop micro needle drug delivery system. 

The report covers detailed analysis of companies which comprises overview, SCOT analysis, product portfolio, strategic initiative, strategic analysis, competitive landscape and market share analysis in the global injectable drug dellivery market.

Key reasons to buy the report:

• The report includes market estimation, forecast and analysis for the year 2016-2023 of the global injectable drug dellivery market.
• Report includes detailed analysis of different segments such as type, formulation, therapeutic application, usage pattern and end users of the global injectable drug dellivery market.
• Identify and understand the strength, opportunities, challenges and threat of the global injectable drug delivery market during the forecast period.
• Covers details analysis of Porters 5 force model and other strategic models. Also covers revenues, market share analysis, competitive landscape analysis of major players of the global injectable drug delivery market.
• Detailed analysis of various the regulatory policies which are affecting the global injectable drug delivery market during the forecast period.

How are we different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on the global injectable drug delivery market offers detailed analysis of strategic models such as investment vs. adoption model, see saw analysis and others strategic models. Also, the report contains the detailed analysis of application, adoption scenario and decision support for each segment. The report discusses competitive landscape of the global injectable drug delivery market, with giving extensive SCOT analysis of key companies.

Key findings of the global injectable drug delivery market:

• Growth in pharmaceutical and biotechnology industry is adding growth in the global injectable drug delivery market during the forecast period.
• North America held highest revenue share in 2016 and is expected to dominate the market during the forecast period.
• Devices segment is expected to dominate the global injectable drug delivery market during the forecast period.
• Partnership is the key strategy adopted by players of the global injectable drug delivery market.

Request for Sample